News
Venture capitalist Michael Moritz's San Francisco Standard is buying Charter and installing co-founder Kevin Delaney as its ...
Philip Morris International Inc. rated Hold with $170 target: strong smoke-free growth & margins vs. peers. Click for PM ...
5h
InvestorsHub on MSNArcturus Therapeutics Stock Rises After Promising Mid-Stage Data for OTC Deficiency TreatmentShares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) edged up 2% after the company shared encouraging interim results ...
Investing.com -- Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) stock rose 2% following positive interim results from two Phase 2 clinical trials of its ARCT-810 mRNA therapeutic for ornithine ...
MIRA READ THE FULL MIRA RESEARCH REPORT MIRA Pharmaceuticals (NASDAQ:MIRA) is a clinical-stage pharmaceutical company focused on the development and commercialization of a new molecular synthetic ...
Our 0.5x FY26E sales multiple reflects a balance between discounting near term volatility, and giving credit for 39% EBITDA margins as scale grows and capital allocation is further optimized though ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results